Nurix Therapeutics, Inc.
USD16.37
-1.02 (-5.87%)
CEO
Arthur T. Sands
IPO Date
2020-07-24
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$17.02
Prev. Close
$17.39
Day Low
$16.29
Day High
$17.23
52W Low
$8.20
52W High
$22.50
Market Cap
$1.42B
Volume
1.05M
| 31,250 |
| $15.86 |
| 15 May 2026 | Reinsdorf Judith A | director | A-Award | Acquired | 31,250 | $15.86 |
| 15 May 2026 | Lacey David L. | director | A-Award | Acquired | 31,250 | $15.86 |
| 15 May 2026 | Kapur Anil | director | A-Award | Acquired | 31,250 | $15.86 |
| 15 May 2026 | DANSEY ROGER D | director | A-Award | Acquired | 31,250 | $15.86 |
| 15 May 2026 | Baynes Roy D. | director | A-Award | Acquired | 31,250 | $15.86 |
| 15 May 2026 | GREGORY JULIA P | director | A-Award | Acquired | 31,250 | $15.86 |
| 5 May 2026 | van Houte Hans | Chief Financial Officer | S-Sale | Disposed | 13,473 | $16.58 |
| 5 May 2026 | van Houte Hans | Chief Financial Officer | S-Sale | Disposed | 582 | $17.18 |